Impact of rheumatoid arthritis on complications and hospital outcomes following reverse shoulder arthroplasty: evidence from 389,135 hospitalizations in the national inpatient sample - Takeaways - MDSpire

Impact of rheumatoid arthritis on complications and hospital outcomes following reverse shoulder arthroplasty: evidence from 389,135 hospitalizations in the national inpatient sample

  • By

  • Assil Mahamid

  • Miri Elgabsi

  • Muhammad Khatib

  • Hamza Murad

  • Feras Qawasmi

  • Eitan Lavon

  • Sana Zahalka

  • Ali Yassin

  • Mustafa Yassin

  • June 14, 2026

  • 0 min

Share

  • 1

    Reverse total shoulder arthroplasty (RTSA) is increasingly utilized in patients with rheumatoid arthritis (RA) for advanced shoulder pathology.

  • 2

    Postoperative complications in RA patients undergoing RTSA include higher rates of urinary tract infections, pulmonary embolism, and prolonged hospitalizations.

  • 3

    Implant-related complications such as prosthesis failures and scapular fractures are more prevalent in RA patients post-RTSA.

  • 4

    The study analyzed 389,135 RTSA hospitalizations from 2016 to 2021, focusing on the impact of RA on postoperative outcomes.

  • 5

    Primary outcomes included prolonged length of stay and acute blood loss anemia, with secondary outcomes encompassing various inpatient complications.

Original Source(s)

Impact of rheumatoid arthritis on complications and hospital outcomes following reverse shoulder arthroplasty: evidence from 389,135 hospitalizations in the national inpatient sample

  • by Assil Mahamid, Miri Elgabsi, Muhammad Khatib, Hamza Murad, Feras Qawasmi, Eitan Lavon, Sana Zahalka, Ali Yassin, Mustafa Yassin

  • June 14, 2026

Related Content

Humeral head replacement for syringomyelia-associated Charcot shoulder arthropathy: a case report and literature review

Exploratory analysis of depressive symptom trajectories before and after hip or knee arthroplasty in geriatric patients

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.